Form 4: Saba Capital Management and Boaz Weinstein Boost Holdings in Gabelli Healthcare & WellnessRx Trust

Saba Capital Management, L.P. and Boaz Weinstein, both 10% owners and directors, have increased their beneficial ownership in Gabelli Healthcare & WellnessRx Trust through recent open market purchases.

Summary

• Saba Capital Management, L.P. and Boaz Weinstein, identified as 10% owners and directors of Gabelli Healthcare & WellnessRx Trust (GRX), reported changes in their beneficial ownership.
• On July 10, 2025, 3,952 shares of Common Stock were acquired at a price of $9.48 per share, increasing beneficial ownership to 1,980,827 shares.
• On July 11, 2025, an additional 6,894 shares of Common Stock were acquired at a price of $9.37 per share, bringing the total beneficial ownership to 1,987,721 shares.
• All reported transactions were purchases (P) of common stock.
• The transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to significant insider buying by a 10% owner and director, indicating strong confidence in the company's valuation and future prospects.

Positives

• Significant insider buying by a 10% owner and director, Saba Capital Management, L.P. and Boaz Weinstein, signals strong confidence in the company's current valuation and future prospects.
• The purchases were made at market prices of $9.48 and $9.37, indicating a belief that the shares are undervalued or poised for growth.

Future Outlook

The document, an SEC Form 4, reports past transactions and does not provide forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Gabelli Healthcare & WellnessRx Trust is a closed-end fund primarily investing in the healthcare and wellness sectors. The insider purchases by Saba Capital Management and Boaz Weinstein suggest a positive outlook on the fund's portfolio performance or the broader healthcare industry, aligning with potential growth opportunities within the sector.

Comparison to Industry Standards

• Insider buying, particularly by significant shareholders and directors like Saba Capital Management and Boaz Weinstein, is widely regarded as a strong positive signal in the investment community.
• Such transactions often indicate that those with the most intimate knowledge of the company believe its shares are undervalued or that significant positive developments are anticipated, a sentiment often mirrored by similar insider activities in other well-managed closed-end funds or healthcare investment vehicles.

Related Party Transactions

• The reported acquisitions of common stock by Saba Capital Management, L.P. and Boaz Weinstein are considered related party transactions, as they are 10% owners and directors of Gabelli Healthcare & WellnessRx Trust.

Stakeholder Impact

• Shareholders: The insider purchases may instill greater confidence among existing shareholders and attract new investors, potentially leading to increased demand and a positive impact on share price.
• Management: The transactions demonstrate alignment of interests between significant owners/directors and other shareholders, reinforcing trust in the company's leadership and strategy.

Key Dates

Recommendation

Keywords

Gabelli Healthcare & WellnessRx Trust, GRX, Saba Capital Management, Boaz Weinstein, Insider Buying, Beneficial Ownership, SEC Form 4, Healthcare Investment, Closed-End Fund, Equity Purchase